Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy

OBJECTIVE:. The CytoSorb hemoadsorption device (CytoSorbents Inc, Monmouth Junction, NJ) is increasingly used in many critical disease states. The potential impact on the pharmacokinetic (PK) of concomitantly administered drugs must be considered in clinical practice. The current review summarizes r...

Full description

Bibliographic Details
Main Authors: Joerg Scheier, MD, Peter J. Nelson, MD, FASN, Antoine Schneider, MD, PhD, Sébastien Colombier, MD, Detlef Kindgen-Milles, MD, PhD, Efthymios N. Deliargyris, MD, FACC, FESC, FSCAI, Thomas D. Nolin, PharmD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2022-05-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000688

Internet

http://journals.lww.com/10.1097/CCE.0000000000000688

Similar Items